Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Reardon Tighe
Acting Chief Financial Officer at Janux Therapeutics. Filing since 15 Jun 2021.
CIK 0001760431
Company
Date
Role
Action
Shares
Amount
Of holding
JANX
Janux Therapeutics, Inc.
3 Jun 2024
Acting Chief Financial Officer
Sold at will
822,721
$45.04M
56.5%
JANX
Janux Therapeutics, Inc.
13 Nov 2023
Acting Chief Financial Officer
Bought
849,854
$4.99M
opened
JANX
Janux Therapeutics, Inc.
15 Jun 2021
Acting Chief Financial Officer
Bought
629,411
$10.70M
16.3%
3 decisions on file.
